Total Mesorectum Excision With Left Colic Artery Preservation for the Treatment of Rectal Cancer
NCT ID: NCT03724591
Last Updated: 2018-10-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
600 participants
INTERVENTIONAL
2019-01-31
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer
NCT05984485
Laparoscopic Assisted Transanal Total Mesorectal Excision for Rectal Cancer in Low Site
NCT03253302
Simple Transanal Local Excision,Transanal Local Excision Following Radiotherapy Versus Total Mesorectum Excision for the Treatment of the Ultra-low T2N0M0 Rectal Cancer
NCT04098471
Transanal Versus Laparoscopic Total Mesorectal Excision: a Cohort
NCT05682794
Multi-Technology Integrated Total Mesorectal Excision Versus Conventional Total Mesorectal Excision for the Treatment of Middle and Distal Rectal Cancer.
NCT06613399
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To achieve a radical dissection of lymph nodes, it is necessary to remove the central lymph nodes at the root of inferior mesenteric artery(IMA) trunk.From the perspectives of lymph nodes dissection and tension-free anastomosis, it is preferred to perform a high ligation of IMA. However, there is still a controversy whether IMA should be high ligated or not. The argument mainly focuses on whether this performance will compromise the blood perfusion of the proximal limb of the anastomosis leading to the occurrence of AL. Some studies suggested that a high ligation did not increase the rate of AL. There are still many surgeons prefer the transection of IMA distal to the left colic artery(LCA) with the intention to preserve a good blood supply of the left colon after the performance of lymph node dissection around IMA. Some studies suggests that the preservation of LCA in anterior resection for mid and low rectal cancer is associated with lower rates of AL. Further investigations are needed to resolve the controversy.
In this study, eligible patients will be randomly allocated to receive total mesorectal excision (TME) for rectal cancer either by a high ligation of IMA without preservation of left colic artery or a low ligation of IMA with preservation of left colic artery. Postoperative complications, including anastomosis leakage, anastomosis bleeding, will be recorded. Patients will be followed up every 3 months for 2 year, every 6 months for 3 years postoperatively to study the long term effects.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
a high ligation of IMA
total mesorectal excision (TME) for rectal cancer by a high ligation of IMA without preservation of left colic artery
a high ligation of IMA
total mesorectal excision (TME) for rectal cancer by a high ligation of IMA without preservation of left colic artery
a low ligation of IMA
total mesorectal excision (TME) for rectal cancer by a low ligation of IMA with preservation of left colic artery
a low ligation of IMA
total mesorectal excision (TME) for rectal cancer by a low ligation of IMA with preservation of left colic artery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
a high ligation of IMA
total mesorectal excision (TME) for rectal cancer by a high ligation of IMA without preservation of left colic artery
a low ligation of IMA
total mesorectal excision (TME) for rectal cancer by a low ligation of IMA with preservation of left colic artery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists(ASA) grade I-III;
* Pathological diagnosis of rectal adenocarcinoma;
* Patients suitable for abdominalperineal resection
* Informed consent;
* No history of familial adenomatous polyposis, ulcerative colitis or Crohn's disease.
Exclusion Criteria
* History of psychiatric disease;
* Use of systemic steroids;
* Simultaneous multiple primary colorectal cancer;
* Preoperative imaging examination results show:1. Tumor involves the surrounding organs and combined organ resection need to be done;2. distant metastasis;3. unable to perform R0 resection;
* History of any other malignant tumor in recent 5 years;
* Patients need emergency operation: mechanic ileus, perforation.
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First Affiliated Hospital with Nanjing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yueming Sun, PhD
Role: STUDY_DIRECTOR
The First Affiliated Hospital with Nanjing Medical University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Fumin Zhang, Professor
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRSYM201810
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.